Clearview Capital Seeks to Add to its Team to Support Growth
Clearview Capital recently raised $550 million Fund IV and is seeking to add to its team at the Associate and Senior Associate levels to support its investing efforts. We would appreciate any referrals you have of talented individuals with the desire to join our team in the following roles: Pre-MBA Associate, Healthcare and Generalist Senior Associate...
Read More
Organic Growth Through Acquisition as Clearview’s Elevation Labs Acquires Colorado Quality Products
Strategic Add-On Expands Capabilities in Rapidly Growing Natural and Organic Markets
August 21, 2018
Elevation Labs, a portfolio company of Clearview Capital Fund III, LP (“Clearview Fund III”), has completed the acquisition of Colorado Quality Products, LLC (“CQP”) of Aurora, CO. This transaction closed on July 27, 2018. In conjunction with the transaction, the portfolio company has been rebranded as Elevation Labs, which serves as a holding company for its three divisions - Northwest Cosmetic Laboratories, LLC (“NCL”), Dream Team Beaute, LLC (“Dream Team”) and CQP... Read More
Clearview’s Rx for Success: the Recapitalization of Apothecare
Clearview Capital Fund III, LP and Starboard Capital Partners, LLC (“Starboard”) announced today the recapitalization, in partnership with management, of Apothecare Pharmacy, LLC (“Apothecare” or the “Company”). The transaction closed on July 17, 2018....
Read More
Muscle Up Marketing Combines with Clearview Capital's Mudlick Mail
Clearview Capital Fund III, LP ("Fund III") announced today that Muscle Up Marketing, LLC ("Muscle Up") has combined with Mudlick Mail, LLC ("Mudlick"). The transaction closed on June 29, 2018....
Read More
Clearview Capital Races to Equity and Mezzanine Fund Closes
Clearview Capital today announced the first and final closings of $550 million Clearview Capital Fund IV ("Fund IV" or the "Equity Fund") and $108 million Clearview Capital Mezzanine Fund I ("Mezzanine Fund I"), which were completed on June 29, 2018. Fund IV closed at its self-imposed hard cap and the Mezzanine Fund I was completed above its target...
Read More
Heard it Through the Grapevine...Clearview Backs Acquisitions of Two CA-Based Vineyard Suppliers by Wilson
Clearview Capital Fund III, LP (“Fund III”) announced today that its portfolio company, Wilson Orchard & Vineyard Supply, LLC (“Wilson”), has completed the acquisitions of Valley Vineyard and Quantum Irrigation. The transactions closed on February 2, 2018 and April 17, 2018, respectively...
Read More
Clearview Partners with Community Medical Services to Combat the Opioid Epidemic
Clearview Capital Fund III, LP (“Fund III”) announced today the acquisition, in partnership with management, of Community Medical Services Holdings, LLC (“CMS” or the “Company”). The transaction closed on March 30, 2018...
Read More
Clearview's Got Mail! With the Acquisition of Mudlick Mail
Clearview Capital Fund III, LP ("Fund III") announced today the acquisition, in partnership with management, of Mudlick Mail, LLC ("Mudlick" or the "Company"). The transaction closed on February 14, 2018...
Read More
Clearview Bids Adieu to the Big Easy by Exiting GCR, Inc.
January 8, 2018
Clearview Capital Fund II, LP (“Fund II”) today announced the sale of its majority interest in GCR, Inc. (“GCR”) to an affiliate of HKW Capital Partners. The transaction closed on December 21, 2017...
Read More
Case Closed: Clearview Exits Xact Data Discovery
January 3, 2018
Clearview Capital Fund III, LP ("Fund III") today announced the sale of its majority interest in Xcellence, Inc. dba Xact Data Discovery ("Xact") to an affiliate of JLL Partners. The transaction closed December 22, 2017...
Read More
